The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2017 / Feb / An Intense Focus on Perfusion
Manufacture Bioprocessing Biopharma Small Molecules Sponsored

An Intense Focus on Perfusion

Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion. Perfusion offers many benefits to bioprocessing, but choosing the right system and the right medium are key.Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion. Perfusion offers many benefits to bioprocessing, but choosing the right system and the right medium are key.

02/23/2017 1 min read

Share

Perfusion systems differ from their fed-batch counterparts in that they permit bioreactors to run continuously over extended periods of time by constantly perfusing fresh medium through the culture, simultaneously providing fresh nutrients for the cells and removing waste products. The key advantages of perfusion technology include higher yields per volume, increased flexibility, more consistent product quality and lower capital investment. Furthermore,  perfusion systems can be tweaked to support very high cell densities – this “intensified perfusion” can provide even higher product yields. Here, Delia Lyons, Senior Scientist, at MilliporeSigma, describes the benefits of perfusion in modern bioprocessing.

Figure 1. Volumetric production with three cell lines in benchmark fed-batch system compared to perfusion.

For more information about perfusion, please contact delia.lyons@sial.com

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Choosing a Sterile Fill-Finish Partner
Outsourcing
Choosing a Sterile Fill-Finish Partner

October 22, 2026

5 min read

Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner

Can Clinical Trials Collect Less Data Without Compromising Safety?
Industry News Development & Clinical Regulation & Standards
Can Clinical Trials Collect Less Data Without Compromising Safety?

October 22, 2026

5 min read

Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.

Analytical Champions: Robert Wethman
Bioprocessing Biopharma Interviews
Analytical Champions: Robert Wethman

October 21, 2026

6 min read

Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing

Musings from The Power List: Andres Sirulnik
Development & Clinical Biopharma Interviews
Musings from The Power List: Andres Sirulnik

October 5, 2026

4 min read

Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: